These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 12878436)

  • 41. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease.
    Snow AD; Mar H; Nochlin D; Kimata K; Kato M; Suzuki S; Hassell J; Wight TN
    Am J Pathol; 1988 Dec; 133(3):456-63. PubMed ID: 2974240
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease.
    Snow AD; Kinsella MG; Parks E; Sekiguchi RT; Miller JD; Kimata K; Wight TN
    Arch Biochem Biophys; 1995 Jun; 320(1):84-95. PubMed ID: 7793988
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein.
    Coria F; Castaño EM; Frangione B
    Am J Pathol; 1987 Dec; 129(3):422-8. PubMed ID: 3322021
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection and quantitation of perlecan mRNA levels in Alzheimer's disease and normal aged hippocampus by competitive reverse transcription-polymerase chain reaction.
    Maresh GA; Erezyilmaz D; Murry CE; Nochlin D; Snow AD
    J Neurochem; 1996 Sep; 67(3):1132-44. PubMed ID: 8752120
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heparan Sulfate Proteoglycans in Tauopathy.
    Zhu Y; Gandy L; Zhang F; Liu J; Wang C; Blair LJ; Linhardt RJ; Wang L
    Biomolecules; 2022 Nov; 12(12):. PubMed ID: 36551220
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of proteoglycans and glycosaminoglycans in bovine renal AA-type amyloidosis.
    Niewold TA; Flores Landeira JM; van den Heuvel LP; Ultee A; Tooten PC; Veerkamp JH
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(5):321-8. PubMed ID: 1685039
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of beta-amyloid in the development of Alzheimer's disease.
    Ii K
    Drugs Aging; 1995 Aug; 7(2):97-109. PubMed ID: 7579788
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The antimicrobial protection hypothesis of Alzheimer's disease.
    Moir RD; Lathe R; Tanzi RE
    Alzheimers Dement; 2018 Dec; 14(12):1602-1614. PubMed ID: 30314800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Basement membrane and beta amyloid fibrillogenesis in Alzheimer's disease.
    Inoue S
    Int Rev Cytol; 2001; 210():121-61. PubMed ID: 11580205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acetylcholinesterase and its association with heparan sulphate proteoglycans in cortical amyloid deposits of Alzheimer's disease.
    Kalaria RN; Kroon SN; Grahovac I; Perry G
    Neuroscience; 1992 Nov; 51(1):177-84. PubMed ID: 1465181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of amino-acid substitutions on Alzheimer's amyloid-beta peptide-glycosaminoglycan interactions.
    McLaurin J; Fraser PE
    Eur J Biochem; 2000 Nov; 267(21):6353-61. PubMed ID: 11029577
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease.
    Kisilevsky R; Lemieux LJ; Fraser PE; Kong X; Hultin PG; Szarek WA
    Nat Med; 1995 Feb; 1(2):143-8. PubMed ID: 7585011
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proteoglycans and the acute-phase response in Alzheimer's disease brain.
    Leveugle B; Fillit H
    Mol Neurobiol; 1994; 9(1-3):25-32. PubMed ID: 7888102
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An interaction between basement membrane and Alzheimer amyloid precursor proteins suggests a role in the pathogenesis of Alzheimer's disease.
    Narindrasorasak S; Altman RA; Gonzalez-DeWhitt P; Greenberg BD; Kisilevsky R
    Lab Invest; 1995 Mar; 72(3):272-82. PubMed ID: 7898047
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Heparan sulfate proteoglycans in amyloidosis.
    Zhang X; Li JP
    Prog Mol Biol Transl Sci; 2010; 93():309-34. PubMed ID: 20807650
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amyloidosis in Alzheimer's disease.
    Allsop D; Williams CH
    Biochem Soc Trans; 1994 Feb; 22(1):171-5. PubMed ID: 8206218
    [No Abstract]   [Full Text] [Related]  

  • 58. Perlecan Domain V Inhibits Amyloid-β Induced Activation of the α2β1 Integrin-Mediated Neurotoxic Signaling Cascade.
    Parham CL; Shaw C; Auckland LD; Dickeson SK; Griswold-Prenner I; Bix G
    J Alzheimers Dis; 2016 Oct; 54(4):1629-1647. PubMed ID: 27636841
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of sulfate ions on Alzheimer beta/A4 peptide assemblies: implications for amyloid fibril-proteoglycan interactions.
    Fraser PE; Nguyen JT; Chin DT; Kirschner DA
    J Neurochem; 1992 Oct; 59(4):1531-40. PubMed ID: 1402902
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The sulfate moieties of glycosaminoglycans are critical for the enhancement of beta-amyloid protein fibril formation.
    Castillo GM; Lukito W; Wight TN; Snow AD
    J Neurochem; 1999 Apr; 72(4):1681-7. PubMed ID: 10098877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.